Novel Insertional Mutation in the Bone Morphogenetic Protein Receptor Type II Associated With Sporadic Primary Pulmonary Hypertension
スポンサーリンク
概要
- 論文の詳細を見る
Primary pulmonary hypertension (PPH), which results from occlusion of small pulmonary arteries, is a devastating condition. Mutations of the bone morphogenetic protein receptor type II gene (BMPR2), a component of the transforming growth factor- β (TGF-β) family, which plays a key role in cell growth, have recently been identified as causing familial and sporadic PPH. The first case of BMPR2 mutation found in Japan is reported here in a 19-year-old woman with a clinical diagnosis of PPH and no identifiable family history of pulmonary hypertension. Direct sequencing of the entire coding region and intron/exon boundaries of BMPR2 revealed a frameshift mutation predicted to alter the cell signaling response to specific ligands. A molecular classification of PPH, based upon the presence or absence of BMPR2 mutations, might have important implications for patient management and screening of relatives. (Circ J 2004; 68: 592 - 594)
- 社団法人日本循環器学会の論文
- 2004-05-20
著者
-
Mano Toshiaki
Internal Medicine And Therapeutics Osaka University Graduate School Of Medicine
-
Fujio Yasushi
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Fujio Yasushi
Clinical Evaluation Of Medicines And Therapeutics Graduate School Of Pharmaceutical Sciences Osaka U
-
Fujio Yasushi
Department Of Clinical Evaluation Of Medicines And Therapeutics Graduate School Of Pharmaceutical Sc
-
Kawase Ichiro
Internal Medicine And Therapeutics Osaka University Graduate School Of Medicine
-
Hirota Hisao
Depeasrtment of Cardiovascular Medicine, Graduate School of Medicine, Osaka University
-
Hirota Hisao
Deoartment of Molecular Medicine
-
Sugiyama Shoko
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Hirota Hisao
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Yoshida Maki
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Takemura Yukiko
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Nakaoka Yoshikazu
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Oshima Yuichi
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Terai Kazuhiro
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Izumi Masahiro
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Fujio Yasushi
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Hasegawa Shinji
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Nakatsuchi Yoshiaki
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Hori Masatsugu
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Yamauchi-Takihara Keiko
Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Yoshida Maki
Internal Medicine And Therapeutics Osaka University Graduate School Of Medicine
-
Oshima Yuichi
Osaka Police Hospital
-
Sugiyama Shoko
Department Of Cardiovascular Medicine Osaka University Graduate School Of Medicine
-
Terai Kazuhiro
Department Of Molecular Medicine Osaka University Graduate School Of Medicine
-
Izumi Masahiro
Osaka Medical Center For Cancer And Cardiovascular Disease
-
Hori Masatsugu
Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Hasegawa Shinji
Internal Medicine And Therapeutics Osaka University Graduate School Of Medicine
-
Hirota Hisao
Department Of Cardiovascular Medicine Osaka University Graduate School Of Medicine
-
Nakaoka Yoshikazu
Department Of Cardiovascular Medicine Osaka University Graduate School Of Medicine
-
Izumi Masahiro
Department Of Molecular Medicine Osaka University Graduate School Of Medicine
-
Takemura Yukiko
Internal Medicine And Therapeutics Osaka University Graduate School Of Medicine
-
Hori Masatsugu
Department Of Cardiovascular Medicine Osaka University
-
Fujio Yasushi
Department Of Cardiovascular Medicine Osaka University Graduate School Of Medicine
-
Nakaoka Yoshikazu
Depertment Of Structural Analysis National Cardiovascular Center Research Institute
-
Fujio Yasushi
Department Of Clinical Pharmacology And Pharmacogenomics Graduate School Of Pharmaceutical Sciences
-
Izumi Masahiro
Internal Medicine And Therapeutics Osaka University Graduate School Of Medicine
関連論文
- 1 Pharmacogenomics of β-blocker Therapy in Chronic Heart Failure(New Approaches to Heart Failure-from Pharmacogenomics to Drug Development, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- 5 Clinical Effect of Tolvaptan, an Oral Vasopressin V_2 Receptor Antagonist, in Patients with Chronic Heart Failure (CHF) and Peripheral Edema : Result from a Double-Blind, Randomized Trial(Late Breaking Clinical Trials II,The 73rd Annual Scientific Meeti
- OE-316 Gab Family Scaffolding Adaptor Proteins are Essential Mediators in the Signal Circuit between Myocardium and Endothelium(Molecular biology, myocardium-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-132 Gab Family Proteins Are Essential for the Prevention of Heart Failure(Heart failure, basic-1 (M) OE22,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Novel Insertional Mutation in the Bone Morphogenetic Protein Receptor Type II Associated With Sporadic Primary Pulmonary Hypertension
- Clinical significance of plasma endothelin-1 level after bosentan administration in pulmonary arterial hypertension
- OJ-232 Analysis of Long Term Follow-up (More Than 10years) after Palmaz-Schatz Stenting (Choronic Total Occlusions=CTOs v.s. Non Chronic Total Occlusions=nonCTOs)(Restenosis, basic/clinical-2 (IHD) OJ39,Oral Presentation (Japanese),The 70th Anniversary An
- PJ-829 Effect of Bosentan of Plasma Endothelin-1 Level in Patients with Pulmonary Arterial Hypertension(Pulmonary circulation-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-794 Association of Serotonin Transporter Regulatory Region Polymorphism with Pulmonary Arterial Hypertension(Pulmonary circulation-4 (H) PJ140,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-178 Beneficial Effect of Sildenafil on Hemodynamics and Neurohormonal Activation in Patients with Pulmonary Hypertension(Pulmonary circulation-2 (H) OJ30,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circul
- OE-251 Effect of the Dual Endothelin-receptor Antagonist Bosentan on Plasma Endothlin-1 in Patients with Pulmonary Hypertension(Pulmonary circulation-1 (H) OE42,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Cir
- FRS-003 Docking Protein Gab1 is Essential for HGF-dependent Endothelial Signaling and Angiogenesis after Hindlimb Ischemia(FRS1,New Molecules for Cardiovascular Regulation (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The J
- OE-172 Gab2 is Essential for Angiopoietin-1/Tie2-dependent Signaling and Cytoprotection in Endothelial Cells(Molecular biology, vascular(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-258 BMP2-Smad Signal Protects Cardiomyocytes from Ischemia-Reperfusion Injury through the Induction of β-catenin(Myocardial ischemia/reperfusion, basic/clinical-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-123 Carbacyclin Induces Carnitine Palmitoyltransferase-1 in Cardiomyocytes via Peroxisome Proliferator-Activated Receptor (PPAR) δ Independent of the IP Receptor Signaling Pathway(Metabolism/Biochemistry/Energetics-2, The 71st Annual Scientific Meeting
- Effect of Bosentan on Plasma Endothelin-1 Concentration in Patients With Pulmonary Arterial Hypertension
- Adrenergic β_1 Receptor Polymorphism (Ser49Gly) Is Associated with Obesity in Type II Diabetic Patients(Miscellaneous)
- OJ-155 CYP2A6 Genotypes are Important Factors for Nicotine Dependence and Withdrawal Symptoms in Smoking Cessation(Smoking-1 (H) OJ26,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-761 Gab1-SHP2-ERK Signaling Pathway Comprises and Inhibitory Axis for Insulin-like Growth Factor-1-induced Myogenic Differntiation(Development and differentiation-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-106 Scaffolding/Docking Protein Gab1 Inhibits Myogenic Differentiation through Interaction with Ptotein Tyrosine Phosphatase SHP2(Development and differentiation-2 (M) PE18,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the
- OE-113 Clinical Significance of Plasma Endothelin-1 Level after Bosentan Administration in Pulmonary Arterial Hypertension(OE19,Pulmonary Circulation (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- OE-081 Activation of STATS protects heart from myocardial injury induced by ischemia/reperfusion(Myocardial Ischemia-Reperfusion, Basic and Clinical 1 (IHD) : OE10)(Oral Presentation (English))
- FRS-024 Interaction of Scaffolding/Docking Protein Gab1 with Tyrosine Phosphatase SHP2 Is Involved in gp130-dependent Activation of ERK5 and Elongation of Cardiomyocytes(Cardiac Hypertrophy (M) : FRS3)(Featured Research Session (English))
- Bcl-xL Is Up-Regulated in the Hearts of Cardiac-Specific Smad1 Transgenic Mice
- Targeted Disruption of Gab1 Gene Leads to Developmental Abnormalities in Heart
- Cardiac-specific activation of STAT3 promotes the vessel growth in the hearts
- IS025 Activation of gp130 transduces cytoprotective signals in cardiac myocytes
- 日本人における胆汁酸抱合酵素BAATの新規遺伝子多型
- IS099 Activation of Signal Transducer and Activator of Transcription 3 is Required for gp130-mediated Induction of Vascular Endothelial Growth Factor in Cardiac Myocytes
- Specific Cardiomyopathy Caused by Multisystemic Lipid Storage in Jordans' Anomaly
- OJ-523 Skeletal Alpha-actin Gene Expression Is Negatively Regulated by Protein Tyrosine Phosphatase SHP2 Through Inhibition of Rho signaling Pathway in Cardiomyocytes(Molecular Biology, Myocardium 2 (M) : OJ64)(Oral Presentation (Japanese))
- OJ-436 Mutations of bone morphogenetic protein receptor 2 gene and polymorphism of serotonin transporter gene in patients with primary pulmonary hypertension(Pulmonary Circulation 1 (H) : OJ53)(Oral Presentation (Japanese))
- OE-294 Overexpression of Smad1 Protects against Myocardial Ischemia-reperfusion Injury through Induction of Bcl-xL in Transgenic Mice(Genetics/Genetically Engineered Models 2 (H) : OE36)(Oral Presentation (English))
- Bone Morphogenetic Protein-2 Signaling through Smad1 Inhibits Pulmonary Artery Smooth Muscle Cell Proliferation
- Stat3 Activation Is Responsible for Protecting Cardiac Fibrosis through Inhibiting Stretch-Induced TGFbeta : Generation and Characterization of Cardiac-Specific StatS-Deficient Mice
- Carbacyclin Regurates Fatty Acid β-oxidation in Cardiacmyocytes Independent of the IP Receptor Signaling Pathway (Molecular Biology, Myocardium 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Smad1 Protects Cardiomyocytes from Ischemia-reperfusion Injury(Myocardial Ischemia-reperfusion, Basic 2 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Protein Synthesis is Regulated by Eukaryotic Elongation Factor-2 via AMP-activation Protein Kinase Dependent Pathway in Cardiomyocytes during Hypoxia(Molecular Biology, Myocardium 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Socie
- Cross-talk between BMP2 and LIF through ERK1/2 and Smad1 in Protection against Doxorubicin-induced Injury of Cardiomyocytes(Molecular Biology, Myocardium 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PE-472 AMP-activated Protein Kinase Regulates Protein Translation through Phosphorylation of eEF2 During Hypoxia in Cardiomyocyte(Myocardial Ischemia-Reperfusion, Basic (M) : PE80)(Poster Session (English))
- Cardioprotection from Cardiovascular Risk : from Gene to Population Science(Presidential Lecture,The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Disturbed pyloric motility in Ws/Ws mutant rats due to deficiency of c-kit-expressing interstitial cells of Cajal
- 1 The Novel Downstream Target of Neuregulin-1/ErbB Signaling Pathway for Maintenance of Cardiac Function(Interaction between Myocardium and Vasculature in Heart Failure-Novel Insights from Cytokine Signal Network-,Symposium 8 (SY-08) (IHD),The 73rd Annual
- Specific Cardiomyopathy Caused by Multisystemic Lipid Storage in Jordans Anomaly
- IS068 Akt Mediates IGF-1-mediated Cell Survival and Protects Cardiomyocytes From Ischemia/Reperfusion Injury in Vivo
- Sildenafil and steroid therapy effectively improved POEMS syndrome-associated pulmonary arterial hypertension
- Pulmonary Arterial Hypertension Associated with Chronic Active Epstein-Barr Virus Infection
- Association between osteopontin promoter variants and diastolic dysfunction in hypertensive heart in the Japanese population
- Glycoprotein 130 Cytokine Signal as a Therapeutic Target Against Cardiovascular Diseases
- RGS2 determines the preventive effects of ARBs against vascular remodeling : toward personalized medicine of anti-hypertensive therapy with ARBs
- Endothelial Gab1 Deletion Accelerates Angiotensin II-Dependent Vascular Inflammation and Atherosclerosis in Apolipoprotein E Knockout Mice
- Urgent Management of Rapid Heart Rate in Patients With Atrial Fibrillation/Flutter and Left Ventricular Dysfunction:– Comparison of the Ultra-Short-Acting β1-Selective Blocker Landiolol With Digoxin (J-Land Study) –
- Tocilizumab for the Treatment of Patients With Refractory Takayasu Arteritis